Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab
In conclusion, Trastuzumab in combination with FLOT may have curative potential even for metastatic stages of HER-2-positive GC.Case Rep Gastroenterol 2022;16:80 –88
Source: Case Reports in Gastroenterology - Category: Gastroenterology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | CT Scan | Docetaxel | Eloxatin | Fish | Gastrectomy | Gastric (Stomach) Cancer | Gastroenterology | Hepatocellular Carcinoma | HER2 | Herceptin | Liver | Liver Cancer | Palliative | PET Scan | Taxotere | Urology & Nephrology